Cardiovascular Considerations for Trimix Use

Contraindications and Precautions

The FDA has issued a boxed warning against the use of certain vasodilating agents, including trimix, in patients with prior stroke or TIA due to increased risk of adverse events, as these patients have demonstrated net clinical harm with vasodilating medications 1
Patients with a history of stroke or TIA should avoid trimix completely, and consider alternative non-injectable treatments, according to guidelines from the American Heart Association 1, 2
The American College of Cardiology recommends that patients with recent myocardial infarction (within 3-6 months) should avoid trimix due to potential cardiovascular stress, and wait minimum 3-6 months after MI before considering trimix 3, 4

The American Heart Association recommends ensuring optimal management of underlying cardiovascular conditions, maintaining appropriate antiplatelet/anticoagulant therapy as indicated for their cardiac condition, and considering cardiology consultation before initiating treatment with trimix 3, 4
Patients with cardiovascular history should be on appropriate secondary prevention medications for their cardiovascular condition, as recommended by the American College of Cardiology 3, 4

For patients with absolute contraindications to trimix, the American Urological Association recommends considering oral PDE5 inhibitors (if not contraindicated by nitrate use), vacuum erection devices, or penile prosthesis for severe cases 1, 2

The American College of Cardiology recommends monitoring blood pressure before and after initial administration of trimix, providing clear instructions on when to seek emergency care, and regular follow-up to assess cardiovascular status 3, 4
Discontinue trimix immediately if any concerning symptoms develop (chest pain, dizziness, severe headache), as recommended by the American Heart Association 1, 2